EpiEndo Pharmaceuticals
Reykjavik · Founded 2014
- Headquarters
- Reykjavik
- Founded
- 2014
- Business Model
- B2B
- Website
- epiendo.com
About
EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing oral drugs for chronic respiratory diseases, with a focus on the high unmet need of COPD patients. Its lead compound, glasmacinal (formerly EP395), is a non-antibiotic macrolide designed to retain the anti-inflammatory and host-defense benefits of azithromycin without promoting antimicrobial resistance. A semi-virtual company headquartered in Iceland, EpiEndo has staff across Iceland, Sweden, Denmark, and the UK.
Summary
EpiEndo Pharmaceuticals is a Biotech company based in Reykjavik, founded in 2014.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company